Clinical Trial Detail

NCT ID NCT02601209
Title Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

fibrous histiocytoma

leiomyosarcoma

malignant peripheral nerve sheath tumor

synovial sarcoma

sarcoma

Therapies

Pazopanib

Sapanisertib

Age Groups: adult

No variant requirements are available.